UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - t-cells
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Synthetic Viscoelastic Activating Cells (SynVACs) for T cell engineering (UCLA Case No. 2023-190)
UCLA researchers in the Department of Bioengineering have developed a novel microfluidic device that produces synthetic viscoelastic cells for efficacious therapeutic T cell activation. BACKGROUND: T cell-based therapies, such as the chimeric antigen receptor (CAR) T cell therapy, represents a significant advancement in cancer treatment, particularly...
Published: 11/15/2024
|
Inventor(s):
Zeyang Liu
,
Song Li
,
Lili Yang
,
Yan-Ruide Li
Keywords(s):
CAR-T cell therapy
,
Synthetic antigen presenting cells (SynVACs)
,
T Cell
,
T cell based therapy
,
T-cell activation
,
T-cell engineering
,
t-cells
Category(s):
Therapeutics > Oncology
Targeting Prostate Cancer with a Novel T-Cell Receptor and Tissue-Specific Cancer Antigens for Improved Immune Response (UCLA Case No. 2022-070)
Researchers from UCLA’s Department of Microbiology, Immunology, & Molecular Genetics (MIMG), and the department of Molecular and Medical Pharmacology have identified a set of tissue-specific antigens which have been used to isolate and characterize a group of novel T-cell receptors (TCRs) which target prostate cancer specifically. Furthermore,...
Published: 11/15/2024
|
Inventor(s):
Owen Witte
,
Zhiyuan Mao
,
Jami Witte
,
Pavlo Nesterenko
,
John Lee
Keywords(s):
Cancer
,
cancer antigen
,
Peptide
,
peptides
,
prostate cancer
,
protein
,
t-cells
Category(s):
Therapeutics
,
Therapeutics > Oncology > Oncology Immunotherapy
,
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy